OR11-005 - Mast cells respond to pathogen signals with IL-1ß

OR11-005 - Mast cells respond to pathogen signals with IL-1ß

Bibliographic Details
Main Authors:	Kraas, L, Schmetzer, O, Krause, K, Latz, E, Maurer, M
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953109/

Similar Items

Mast Cells Respond to Cell Injury through the Recognition of IL-33
by: Lunderius-Andersson, Carolina, et al.
Published: (2012)

The role of IL-33 and mast cells in allergy and inflammation
by: Saluja, Rohit, et al.
Published: (2015)

Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11
by: Sayama, Koichi, et al.
Published: (2002)

P01-005 – Idiopathic uveitis and FMF
by: Salehzadeh, F, et al.
Published: (2013)

PW03-005 - NLRP3-Q705K monocytes do not produce more IL-1B
by: Simon, G, et al.
Published: (2013)

Mast Cells Express 11β-hydroxysteroid Dehydrogenase Type 1: A Role in Restraining Mast Cell Degranulation
by: Coutinho, Agnes E., et al.
Published: (2013)

Cytoskeleton in Mast Cell Signaling
by: Dráber, Pavel, et al.
Published: (2012)

Targeting IL-11 signaling in colon cancer
by: Ernst, Matthias, et al.
Published: (2013)

OR10-005 - Treatment responses in TRAPS: Eurofever/ Eurotraps
by: Lachmann, HJ, et al.
Published: (2013)

The Role of Mast Cells in the Defence against Pathogens
by: Urb, Mirjam, et al.
Published: (2012)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
by: Hashkes, PJ, et al.
Published: (2013)

OR6-005 – Cystine crystals activate inflammasomes
by: Prencipe, G, et al.
Published: (2013)

AB005. Treatment of Peyronie’s disease: 2016 updates
by: Lue, Tom F.
Published: (2016)

Halometasone monohydrate (0.05%) in occupational contact dermatitis
by: Maiti, Rituparna, et al.
Published: (2016)

AB005. The role of serendipity in sexual medicine
by: Stecher, Vera
Published: (2015)

Intraoperative injuries during liver resection: analysis of 1,005 procedures
by: Grat, Michal, et al.
Published: (2011)

IL–1β and IL–18: inflammatory markers or mediators of hypertension?
by: Krishnan, S M, et al.
Published: (2014)

High-quality complete genome sequence of Microbacterium sp. SUBG005, a plant pathogen
by: Rakhashiya, Purvi M., et al.
Published: (2015)

Role and regulation of phosphatidylinositol 3-kinase ß in platelet integrin α2ß1 signaling
by: Consonni, A., et al.
Published: (2012)

P03-005 - MEFV heterozygous mutations in PFAPA patients
by: Kozlova, A, et al.
Published: (2013)

Role and Relevance of Mast Cells in Fungal Infections
by: Saluja, R., et al.
Published: (2012)

SS Efficient execution vital for policies' success, 11 May 2013
by: New Sarawak, Tribune
Published: (2013)

PW01-005 – Effects of placebo and colchicine on FMF patients
by: Özaltın, F, et al.
Published: (2013)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue, Kenji, et al.
Published: (2012)

Origin of colossal dielectric permittivity of rutile Ti0.9In0.05Nb0.05O2: single crystal and polycrystalline
by: Song, Yongli, et al.
Published: (2016)

P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6
by: Dueckers, G, et al.
Published: (2013)

Mucin 1, a signal transduction membrane-bound mucin, is present in human disc tissue and is downregulated in vitro by exposure to IL-1ß or TNF-α
by: Helen E. Gruber, et al.
Published: (2017-05-01)

TGF-ß1 signalling, connecting aberrant inflammation and colorectal tumorigenesis
by: Paterson, I.C., et al.
Published: (2012)

IL-4–Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-α Production in Mast Cells
by: Suzuki, Kotaro, et al.
Published: (2003)

IL-33 promotes MHC class II expression in murine mast cells
by: Ito, Tomonobu, et al.
Published: (2015)

Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
by: Neto, Rafael T, et al.
Published: (2013)

IL-11 in multiple sclerosis
by: Zhang, Xin, et al.
Published: (2015)

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase
Published: (1991)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
by: Nakakura, Shunsuke, et al.
Published: (2012)

Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
by: Halova, Ivana, et al.
Published: (2012)

TLR signaling in mast cells: common and unique features
by: Sandig, Hilary, et al.
Published: (2012)

IL-27 Receptor Signalling Restricts the Formation of Pathogenic, Terminally Differentiated Th1 Cells during Malaria Infection by Repressing IL-12 Dependent Signals
by: Villegas-Mendez, Ana, et al.
Published: (2013)

Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
by: Tao, Leilei, et al.
Published: (2016)

IL-11 and IL-11Rα immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development
by: Dimitriadis, E, et al.
Published: (2003)

Inflammasome/IL-1β Responses to Streptococcal Pathogens
by: LaRock, Christopher N., et al.
Published: (2015)